<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25340972</article-id>
      <article-id pub-id-type="pmc">4214306</article-id>
      <article-id pub-id-type="publisher-id">14-0525</article-id>
      <article-id pub-id-type="doi">10.3201/eid2011.140525</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dispatch</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Dispatch</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject>ESBL-Producing <italic>Salmonella enterica</italic> Serovar Typhi in Traveler Returning from Guatemala to Spain</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>ESBL-Producing <italic>Salmonella enterica</italic> Serovar Typhi in Traveler Returning from Guatemala to Spain</article-title>
        <alt-title alt-title-type="running-head">ESBL-Producing <italic>S. enterica</italic> Ser. Typhi</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Gonz&#xE1;lez-L&#xF3;pez</surname>
            <given-names>Juan Jos&#xE9;</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piedra-Carrasco</surname>
            <given-names>Nuria</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salvador</surname>
            <given-names>Fernando</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodr&#xED;guez</surname>
            <given-names>Virginia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>S&#xE1;nchez-Montalv&#xE1;</surname>
            <given-names>Adri&#xE1;n</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Planes</surname>
            <given-names>Anna M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Molina</surname>
            <given-names>Israel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Larrosa</surname>
            <given-names>M. Nieves</given-names>
          </name>
        </contrib>
        <aff id="aff1">Hospital Vall d&#x2019;Hebron, Barcelona, Spain (J.J. Gonz&#xE1;lez-L&#xF3;pez, N. Piedra-Carrasco, F. Salvador, V. Rodr&#xED;guez, A. S&#xE1;nchez-Montalv&#xE1;, A.M. Planes, I. Molina, M.N. Larrosa); </aff>
        <aff id="aff2">Universitat Aut&#xF2;noma de Barcelona, Barcelona (J.J. Gonz&#xE1;lez-L&#xF3;pez, N. Piedra-Carrasco, M.N. Larrosa)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Juan Jos&#xE9; Gonz&#xE1;lez-L&#xF3;pez, Department of Microbiology, Hospital Vall d&#x2019;Hebron, Pg Vall d&#x2019;Hebron 119-129, 08035 Barcelona, Spain; email: <email xlink:href="jjgonzal@vhebron.net">jjgonzal@vhebron.net</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <volume>20</volume>
      <issue>11</issue>
      <fpage>1918</fpage>
      <lpage>1920</lpage>
      <abstract>
        <p>We report a case of typhoid fever in a traveler returning to Spain from Guatemala that was caused by <italic>Salmonella enterica</italic> serovar Typhi which produced an extended-spectrum &#x3B2;-lactamase (ESBL). This finding demonstrates the presence of ESBL-producing <italic>S. enterica</italic> ser. Typhi strains in the Americas. Enhanced surveillance is necessary to prevent further spread.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Salmonella enterica</kwd>
        <kwd>Typhi</kwd>
        <kwd>typhoid fever</kwd>
        <kwd>ESBL</kwd>
        <kwd>CTX-M-15</kwd>
        <kwd>CTX-M</kwd>
        <kwd>salmonellae</kwd>
        <kwd>extended-spectrum &#x3B2;-lactamase</kwd>
        <kwd>&#x3B2;-lactams</kwd>
        <kwd>bacteria</kwd>
        <kwd>Americas</kwd>
        <kwd>Guatemala</kwd>
        <kwd>Spain</kwd>
        <kwd>travel</kwd>
        <kwd>Salmonella enterica serovar Typhi</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><italic>Salmonella enterica</italic> serovar Typhi is the causative agent of typhoid fever, an enteric bacterial infection that results in systemic febrile illness. <italic>S. enterica</italic> ser. Typhi is strictly adapted to humans; its transmission occurs through the fecal-oral route, person-to-person contact, or contaminated water or food. An estimated 22 million new cases of typhoid fever occur each year worldwide, resulting in 200,000 deaths (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). <italic>S. enterica</italic> ser. Typhi infection is uncommon in industrialized countries, where infections occur sporadically and mainly in travelers returning from disease-endemic areas and in newly arrived immigrants.</p>
    <p>Chloramphenicol was used successfully as the first-line agent for the treatment of typhoid fever from the 1950s through the 1970s. Strains resistant to this compound emerged in 1972, associated with self-transferable <italic>Inc</italic>HI plasmids. Trimethoprim-sulfamethoxazole and ampicillin were then employed, but strains resistant to all 3 drugs arose rapidly during the 1980s and 1990s in southern and Southeast Asia, the Middle East, and Africa (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref><italic>,</italic><xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). To overcome these new resistances, fluoroquinolones were proposed as the drug of choice. However, during the past decade, ciprofloxacin-resistant strains have been reported in the Asian subcontinent (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>).This situation has resulted in the use of ceftriaxone or cefotaxime as alternatives for treatment of enteric fever (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>).</p>
    <p>Until now, extended-spectrum &#x3B2;-lactamase (ESBL)&#x2013;producing <italic>S. enterica</italic> ser. Typhi strains have been uncommon and have been described only in a few patients of Asian origin and in travelers returning from that region (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>&#x2013;</italic><xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). We report the detection and molecular characterization of an ESBL-producing <italic>S. enterica</italic> ser. Typhi strain isolated in Barcelona, Spain, from a patient with typhoid fever who had traveled to Guatemala.</p>
    <sec>
      <title>The Study</title>
      <p>In September 2013, a 41-year-old man residing in Barcelona visited the emergency room of the Vall d&#x2019;Hebron Hospital, reporting 10 days of fever and pain in the right upper abdominal quadrant, preceded by 3 days of diarrhea. At the time of his hospital visit, the patient had been back in Spain for 4 days after a 5-month stay in rural Guatemala. Physical examination revealed a temperature of 37.8&#xB0;C and unremarkable blood pressure and heart rate results. Abdominal examination showed tenderness of the right upper and lower quadrants. General biochemistry values and blood cell counts were within reference ranges, but C-reactive protein level and erythrocyte sedimentation rate were elevated. Results of initial blood and stool culture testing were negative. Because of the patient&#x2019;s persistent abdominal pain and newly documented fever, computed tomographic scan of the abdomen was performed; results showed thickening of the terminal ileum, adjacent fat tissue stranding, and regional lymphadenopathy. Antimicrobial drug treatment with amoxicillin-clavulanate acid was begun. New blood cultures, performed because of the patient&#x2019;s persistent fever, yielded <italic>S. enterica</italic> ser. Typhi, and the strain produced an ESBL. Subsequently, intravenous ertapenem (1 g/d) was administered for 14 days; the patient experienced complete clinical recovery, and subsequent blood and stool culture results were negative.</p>
      <p>The isolate was identified by using the VITEK2 system (bioM&#xE9;rieux, Marcy l&#x2019;Etoile, France). Serotyping by slide agglutination by using commercial antisera according to the Kauffmann-White scheme yielded the antigenic formula 9,12,[Vi]:d:-. Multilocus sequence typing (MLST), which was done using primers described elsewhere (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>) with allele sequences and allelic profiles verified in the MLST database (<ext-link ext-link-type="uri" xlink:href="http://mlst.ucc.ie/mlst/dbs/Senterica">http://mlst.ucc.ie/mlst/dbs/Senterica</ext-link>), showed that the strain belonged to sequence type (ST) 2. This ST is one of the most prevalent among <italic>S. enterica</italic> ser. Typhi; isolates of this ST have been detected in Asia, Africa, and South America (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>).</p>
      <p>Antimicrobial susceptibility to &#x3B2;-lactams was assessed by disk diffusion following Clinical Laboratory Standards Institute recommendations (<ext-link ext-link-type="uri" xlink:href="http://www.clsi.org">http://www.clsi.org</ext-link>). Suggestive evidence of ESBL production was observed as synergy between amoxicillin/clavulanate and <underline>&gt;</underline>1 of the following: cefotaxime, ceftazidime, aztreonam, and cefepime. In addition, MICs of &#x3B2;-lactams, quinolones, trimethoprim/sulfamethoxazole, chloramphenicol, and azithromycin were determined by E-test (bioM&#xE9;rieux) (<xref ref-type="table" rid="T1">Table</xref>). According to Clinical Laboratory Standards Institute interpretative criteria, the isolate was resistant to all &#x3B2;-lactams evaluated except amoxicillin/clavulanate, piperacillin/tazobactam, cefoxitin, and carbapenems and was susceptible to chloramphenicol, trimethoprim/sulfamethoxazole, nalidixic acid, ciprofloxacin, and gentamicin. The MIC of azithromycin was 4 &#xB5;g/mL; according to the European Committee on Antimicrobial Susceptibility Testing (<ext-link ext-link-type="uri" xlink:href="http://www.eucast.org">http://www.eucast.org</ext-link>), isolates with an MIC &#x2264;16 &#x3BC;g/mL of this drug should be considered wild-type organisms that are expected to respond to treatment (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>).</p>
      <table-wrap id="T1" position="float">
        <label>Table</label>
        <caption>
          <title>Susceptibility profiles of the CTX-M-15&#x2013;producing <italic>Salmonella enterica</italic> serovar Typhi strain from a patient in Spain who had traveled to Guatemala in 2013, compared with profiles of the <italic>Escherichia coli</italic> recipient strain and the transconjugant strain</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="192" span="1"/>
          <col width="84" span="1"/>
          <col width="93" span="1"/>
          <col width="111" span="1"/>
          <thead>
            <tr>
              <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Antimicrobial agent(s)</th>
              <th valign="bottom" colspan="3" align="center" scope="colgroup" rowspan="1">MIC, &#xB5;g/mL<hr/></th>
            </tr>
            <tr>
              <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1"><italic>S. enterica</italic> ser. Typhi 301812 (donor)</th>
              <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><italic>E. coli</italic> HB101-Nal (recipient)</th>
              <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><italic>E. coli</italic> HB101-Nal TC-301812 (transconjugant)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ampicillin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amoxicillin-clavulanate</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperacillin-tazobactam</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.5</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefoxitin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftazidime</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.064</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefotaxime</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.016</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefotaxime-clavulanate</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.19</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.016</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.016</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefepime</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.032</td>
              <td valign="top" align="center" rowspan="1" colspan="1">24</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Aztreonam</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.016</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Imipenem</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Meropenem</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.064</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.023</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.023</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ertapenem</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.064</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.002</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.002</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chloramphenicol</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Trimethoprim-sulfamethoxazole</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.047</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.25</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nalidixic acid</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciprofloxacin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.023</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.125</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.125</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Azithromycin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gentamicin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.75</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tobramycin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">24</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amikacin</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;256</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>To screen for TEM and SHV &#x3B2;-lactamases, CTX-M ESBL genes, and genes encoding resistance to quinolones (<italic>qnrA</italic>, <italic>qnrB</italic>, <italic>qnrS, qepA, oqxAB,</italic> and <italic>acc(6&#x2032;)-Ib-cr</italic>), we used PCR as described previously (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref><italic>,</italic><xref rid="R12" ref-type="bibr"><italic>12</italic></xref>). Mutations in <italic>aac(6&#x2032;)-Ib</italic> that confer quinolone resistance and in the quinolone resistance&#x2013;determining regions of <italic>gyrA, gyrB</italic>, <italic>parC</italic>, and <italic>parE</italic>, were studied by sequencing (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref><italic>,</italic><xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). These experiments showed that the <italic>S. enterica</italic> ser. Typhi isolate possessed <italic>bla</italic><sub>TEM-1</sub>, <italic>bla</italic><sub>CTX-M-15</sub>, and <italic>acc(6&#x2032;)-Ib</italic> but none of the studied quinolone resistance genes or detectable quinolone resistance&#x2013;determining region mutations.</p>
      <p>IS<italic>Ecp1</italic>, IS<italic>26</italic>, and <italic>orf</italic>477 are elements that previously have been identified in the genetic environment surrounding <italic>bla</italic><sub>CTX-M-15</sub>. The presence of such elements was investigated by PCR mapping and sequencing in combination with <italic>bla</italic><sub>CTX-M-15</sub>&#x2013;specific primers, as reported previously (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>).These results showed that the ESBL gene was situated between a nontruncated IS<italic>Ecp1</italic> and <italic>orf</italic>477, as noted previously in other <italic>Enterobacteriaceae</italic>.</p>
      <p>Identification and characterization of the location of <italic>bla</italic><sub>CTX-M-15</sub> was carried out by conjugation, using a nalidixic acid&#x2013;resistant derivative of <italic>Escherichia coli</italic> HB101 as recipient, PFGE of total DNA of donor and transconjugant digested with S1-nuclease, Southern hybridization with specific probes, and PCR-based replicon typing, as described previously (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>). These studies showed that the <italic>S. enterica</italic> ser. Typhi <italic>bla</italic><sub>CTX-M-15</sub> was located in an IncL/M self-transferrable plasmid of 65 kb that also carried the <italic>bla</italic><sub>TEM-1</sub> and <italic>acc(6&#x2032;)-Ib</italic> genes. MICs to antimicrobial agents for donor, recipient, and transconjugant are shown in the <xref ref-type="table" rid="T1">Table</xref>.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>We describe an ESBL-producing <italic>S. enterica</italic> ser. Typhi strain isolated from a man in Spain who had traveled to Guatemala. It is well documented that ESBL<italic>-</italic>producing <italic>Enterobacteriaceae</italic> are spreading worldwide. CTX-M-15 is one of the most commonly identified ESBLs; its high prevalence has been driven mainly by the pandemic spread and expansion of the ST131 <italic>E. coli</italic> clonal group. Extended-spectrum cephalosporin resistance has increased during the past few years in nontyphoidal <italic>S. enterica</italic>, principally in developing countries, where such resistance appears to be endemic in some areas (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>).</p>
      <p>To our knowledge, 5 cases of <italic>S. enterica</italic> ser. Typhi resistant to &#x3B2;-lactams by ESBL production have been reported, all with Asian origins (Bangladesh, the Philippines, Iraq, and India) (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>&#x2013;</italic><xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). For the isolate originating in the Philippines, SHV-12 was the enzyme responsible for ESBL resistance (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>); for the other 4 isolates, a CTX-M enzyme was detected, and in 3 of those, the CTX-M-15 variant was identified (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>&#x2013;</italic><xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). In our case, however, we found a different genetic environment of <italic>bla</italic><sub>CTX-M-15</sub>. Specifically, we found a nontruncated IS<italic>Ecp1</italic> upstream of <italic>bla</italic><sub>CTX-M-15</sub>, whereas in the previously reported Iraq-origin strain, IS<italic>Ecp1</italic> was truncated by IS<italic>26</italic> (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). Genetic environments of <italic>bla</italic><sub>CTX-M-15</sub>&#x2013;producing <italic>S. enterica</italic> ser. Typhi isolates from India are not clear, but according to the methods used by the authors (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>), a truncated IS<italic>Ecp1</italic> or a different structure may have been involved. Our results also confirm that the plasmid harboring <italic>bla</italic><sub>CTX-M-15</sub>, which also carries <italic>bla</italic><sub>TEM-1</sub> and <italic>acc(6&#x2032;)-Ib</italic>, carries an IncL/M replicon.</p>
      <p>In summary, we report a case of typhoid fever caused by an ESBL-producing <italic>S. enterica</italic> ser. Typhi isolate from a traveler returning to Spain from Guatemala. This case represents the acquisition of an ESBL-producing <italic>S. enterica</italic> ser. Typhi strains in the Americas. Because typhoid fever is a serious public health issue, meticulous microbiological and epidemiologic investigation of strains of this sort are necessary to prevent further spread of this disease.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Gonz&#xE1;lez-L&#xF3;pez JJ, Piedra-Carrasco N, Salvador F, Rodr&#xED;guez V, S&#xE1;nchez-Montalva A, Planes AM, et al. ESBL-producing <italic>Salmonella enterica</italic> serovar Typhi in traveler returning from Guatemala to Spain. Emerg Infect Dis [Internet]. 2014 Nov [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2011.140525">http://dx.doi.org/10.3201/eid2011.140525</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We are grateful to J.R. Johnson and G. Prats for critically reading and providing helpful comments during the writing of the manuscript.</p>
      <p>This study was supported by the Ministerio de Ciencia e Innovaci&#xF3;n, Instituto de Salud Carlos III, co-financed by the European Development Regional Fund, A Way To Achieve Europe, ERDF; the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015/0003); and the Fondo de Investigaci&#xF3;n Sanitaria (grant PI09/01702).</p>
    </ack>
    <bio id="d35e744">
      <p>Dr Gonz&#xE1;lez-L&#xF3;pez is a senior microbiologist at Vall d&#x2019;Hebron Hospital, associate professor at the Universitat Aut&#xF3;noma de Barcelona (Spain), and member of the Spanish Network for Research in Infectious Diseases. His research interests include molecular epidemiology and antimicrobial drug resistance in <italic>Enterobacteriaceae</italic>.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Crump</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Luby</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Mintz</surname>
<given-names>ED</given-names></string-name>. <article-title>The global burden of typhoid fever.</article-title>
<source>Bull World Health Organ</source>. <year>2004</year>;<volume>82</volume>:<fpage>346</fpage>&#x2013;<lpage>53</lpage> .<pub-id pub-id-type="pmid">15298225</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>C-J</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>L-H</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Chiu</surname>
<given-names>C-H</given-names></string-name>. <article-title>First isolation of ciprofloxacin-resistant <italic>Salmonella enterica</italic> serovar Typhi in Taiwan.</article-title>
<source>J Microbiol Immunol Infect</source>. <year>2013</year>;<volume>46</volume>:<fpage>469</fpage>&#x2013;<lpage>73</lpage> . <pub-id pub-id-type="doi">10.1016/j.jmii.2013.01.002</pub-id><pub-id pub-id-type="pmid">23465712</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Parry</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Hien</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Dougan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>White</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Farrar</surname>
<given-names>JJ</given-names></string-name>. <article-title>Typhoid fever.</article-title>
<source>N Engl J Med</source>. <year>2002</year>;<volume>347</volume>:<fpage>1770</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra020201</pub-id><pub-id pub-id-type="pmid">12456854</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Rotimi</surname>
<given-names>VO</given-names></string-name>, <string-name><surname>Jamal</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pal</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sovenned</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Albert</surname>
<given-names>MJ</given-names></string-name>. <article-title>Emergence of CTX-M-15 type extended-spectrum &#x3B2;-lactamase&#x2013;producing <italic>Salmonella</italic> spp. in Kuwait and the United Arab Emirates.</article-title>
<source>J Med Microbiol</source>. <year>2008</year>;<volume>57</volume>:<fpage>881</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.47509-0</pub-id><pub-id pub-id-type="pmid">18566147</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Pfeifer</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Matten</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rabsch</surname>
<given-names>W</given-names></string-name>. <article-title><italic>Salmonella enterica</italic> serovar Typhi with CTX-M &#x3B2;-lactamase, Germany</article-title>
<comment>[letter]</comment>. <source>Emerg Infect Dis</source>. <year>2009</year>;<volume>15</volume>:<fpage>1533</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3201/eid1509.090567</pub-id><pub-id pub-id-type="pmid">19788837</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Ahmed</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hoque</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mazumder</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nahar</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Islam</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gazi</surname>
<given-names>SA</given-names></string-name>, <etal/>
<article-title>Salmonella enterica serovar Typhi strain producing extended-spectrum &#x3B2;-lactamases in Dhaka, Bangladesh.</article-title>
<source>J Med Microbiol</source>. <year>2012</year>;<volume>61</volume>:<fpage>1032</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.044065-0</pub-id><pub-id pub-id-type="pmid">22442289</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Al Naiemi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Zwart</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Rijnsburger</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Roosendaal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Debets-Ossenkopp</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Mulder</surname>
<given-names>JA</given-names></string-name>, <etal/>
<article-title>Extended-spectrum-beta-lactamase production in a <italic>Salmonella enterica</italic> serotype Typhi strain from the Philippines.</article-title>
<source>J Clin Microbiol</source>. <year>2008</year>;<volume>46</volume>:<fpage>2794</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00676-08</pub-id><pub-id pub-id-type="pmid">18550740</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Achtman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wain</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Weill</surname>
<given-names>F-X</given-names></string-name>, <string-name><surname>Nair</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Sangal</surname>
<given-names>V</given-names></string-name>, <etal/>
<article-title>Multilocus sequence typing as a replacement for serotyping in <italic>Salmonella enterica.</italic></article-title>
<source>PLoS Pathog</source>. <year>2012</year>;<volume>8</volume>:<fpage>e1002776</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002776</pub-id><pub-id pub-id-type="pmid">22737074</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kidgell</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Reichard</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Wain</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Linz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Torpdahl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dougan</surname>
<given-names>G</given-names></string-name>, <etal/>
<article-title><italic>Salmonella typhi</italic>, the causative agent of typhoid fever, is approximately 50,000 years old.</article-title>
<source>Infect Genet Evol</source>. <year>2002</year>;<volume>2</volume>:<fpage>39</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/S1567-1348(02)00089-8</pub-id><pub-id pub-id-type="pmid">12797999</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Leclercq</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Cant&#xF3;n</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>DFJ</given-names></string-name>, <string-name><surname>Giske</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Heisig</surname>
<given-names>P</given-names></string-name>, <string-name><surname>MacGowan</surname>
<given-names>AP</given-names></string-name>, <etal/>
<article-title>EUCAST expert rules in antimicrobial susceptibility testing: EUCAST expert rules.</article-title>
<source>Clin Microbiol Infect</source>. <year>2013</year>;<volume>19</volume>:<fpage>141</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03703.x</pub-id><pub-id pub-id-type="pmid">22117544</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lavilla</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gonz&#xE1;lez-L&#xF3;pez</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Sabat&#xE9;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Garc&#xED;a-Fern&#xE1;ndez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Larrosa</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Bartolom&#xE9;</surname>
<given-names>RM</given-names></string-name>, <etal/>
<article-title>Prevalence of <italic>qnr</italic> genes among extended-spectrum &#x3B2;-lactamase&#x2013;producing enterobacterial isolates in Barcelona, Spain.</article-title>
<source>J Antimicrob Chemother</source>. <year>2008</year>;<volume>61</volume>:<fpage>291</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkm448</pub-id><pub-id pub-id-type="pmid">18029415</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>S</given-names></string-name>, <etal/>
<article-title>Prevalence of <italic>qnr, aac(6&#x2019;)-Ib-cr, qepA</italic>, and <italic>oqxAB</italic> in <italic>Escherichia coli</italic> isolates from humans, animals, and the environment.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2012</year>;<volume>56</volume>:<fpage>3423</fpage>&#x2013;<lpage>7</lpage> . <pub-id pub-id-type="doi">10.1128/AAC.06191-11</pub-id><pub-id pub-id-type="pmid">22391545</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Giraud</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Brisabois</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Martel</surname>
<given-names>J-L</given-names></string-name>, <string-name><surname>Chaslus-Dancla</surname>
<given-names>E</given-names></string-name>. <article-title>Comparative studies of mutations in animal isolates and experimental in vitro&#x2013; and in vivo&#x2013;selected mutants of <italic>Salmonella</italic> spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>1999</year>;<volume>43</volume>:<fpage>2131</fpage>&#x2013;<lpage>7</lpage> .<pub-id pub-id-type="pmid">10471553</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Coelho</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gonz&#xE1;lez-L&#xF3;pez</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Mir&#xF3;</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Alonso-Tarr&#xE9;s</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mirelis</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Larrosa</surname>
<given-names>MN</given-names></string-name>, <etal/>
<article-title>Characterisation of the CTX-M-15-encoding gene in <italic>Klebsiella pneumoniae</italic> strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration.</article-title>
<source>Int J Antimicrob Agents</source>. <year>2010</year>;<volume>36</volume>:<fpage>73</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.03.005</pub-id><pub-id pub-id-type="pmid">20392607</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Miriagou</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Tassios</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Legakis</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tzouvelekis</surname>
<given-names>L</given-names></string-name>. <article-title>Expanded-spectrum cephalosporin resistance in non-typhoid <italic>Salmonella.</italic></article-title>
<source>Int J Antimicrob Agents</source>. <year>2004</year>;<volume>23</volume>:<fpage>547</fpage>&#x2013;<lpage>55</lpage> . <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2004.03.006</pub-id><pub-id pub-id-type="pmid">15194124</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
